Skip to content

Accuracy of Computer-aided (CADx) System in Real-time Characterization of Colorectal Ulcerative Diseases

A Prospective Study to Evaluate the Diagnostic Accuracy of Computer-aided (CADx) System in Real-time Characterization of Colorectal Ulcerative Diseases

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06207825
Enrollment
495
Registered
2024-01-17
Start date
2024-01-31
Completion date
2026-06-30
Last updated
2024-01-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colorectal Ulcers, Computer-aided System

Brief summary

The goal of this observational study is to test the diagnostic accuracy of the newly developed CADx system in predicting the histopathology of colorectal ulcers when compared to expert endoscopists. The main question it aims to answer are to demonstrate whether the newly developed CADx system has a high-level diagnostic accuracy in predicting characterization of colorectal ulcerative diseases. It is a multi-center study with two phases. The first retrospective phase is the development and validation of a CADx system by feature extraction from endoscopic photos and videos. The second prospective phase is the evaluation and comparison of the diagnostic accuracy between the CADx system, expert endoscopists and junior endoscopists.

Detailed description

In the first retrospective phase of study, our primary aim is to develop and validate a CADx system. Endoscopic photos and videos will be retrieved from existing database in the study centers (Nanfang Hospital). For each colorectal ulcer, different endoscopic views will be captures.Relevant baseline demographics, laboratory reports, imaging reports, endoscopy reports and histopathology results will be collected for analysis. The location, size and morphology of each colonic lesion will be recorded. The diagnosis of all colorectal ulcerative disease was comprehensively evaluated by independent pathologists and gastroenterologists. In our study, we will focus on the following subtypes of colorectal ulcerative lesions: 1)colorectal cancer (CA);2)Crohn's disease (CD);3)Ulcerative colitis (UC);4)intestinal tuberculosis (ITB);5) ischemic colitis (IC). All data will be de-identified before central processing to ensure confidentiality. A project-specific serial number will be used to represent each individual subject. All clinical data and de-identified endoscopic images will be kept confidential and will not be shared with any third party. A training cohort will be developed from majority of the included cases, followed by a validation cohort with the remaining cases. The endoscopic images and videos will be prepared to train the convoluted neural network and recurrent neural network by selecting appropriate regions of interest (ROI). Multiple ROI within the same colorectal ulcerative disease will be collected to reduce selection bias. Annotation and validation of endoscopic images will be performed by research team. The images will be further segmented into tiles of the same size for further processing. Deep learning algorithms will be applied to learn and extract features on the image and video data. We will develop the recurrent convolutional network to leverage the complementary information of visual and temporal features extracted from the video. Validation data are also created under the same principle which enable cross-validation for model accuracy. In the second prospective phase of study, we aim to compare the diagnostic accuracy between the CADx system, expert endoscopists and junior endoscopists. A set of test images and videos will be collected prospectively from other subjects, according to the previous eligibility criteria, followed by random allocation of computer-generated sequence. Two expert endoscopists (with more than 5 years of experience in colonoscopy and a total number of procedures more than 1,000) and two junior endoscopists (with less than 3 years of experience in colonoscopy and a total number of procedures less than 500), who are blinded to the final diagnostic result, will be invited to classify the test set images and videos according to the pre-defined subtypes. All endoscopists will assess the test set data independently in a real-time basis. On the other hand, the CADx system will scan the test set images and videos independently. The prediction of ulcer subtypes will be recorded. The formal diagnostic report after evaluation by independent pathologists and gastroenterologists will be regarded as the ground truth.

Interventions

DIAGNOSTIC_TESTTest images and videos

A set of test images and videos will be collected prospectively from other subjects, according to the eligibility criteria, followed by random allocation of computer-generated sequence.

Sponsors

Prince of Wales Hospital, Shatin, Hong Kong
CollaboratorOTHER
Longgang District People's Hospital
CollaboratorUNKNOWN
ZhuHai Hospital
CollaboratorOTHER
Wuxi People's Hospital
CollaboratorOTHER
Nanfang Hospital, Southern Medical University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

1. They underwent endoscopic examination and are found to have ulcerative lesions in the large intestine; 2. They have endoscopic images and videos captured and stored during colonoscopy which are available to be retrieved; 3. They have the complete medical records and clear diagnosis.

Exclusion criteria

1)Poor quality endoscopic images and videos defined as: 1. Incomplete visualization of the colorectal ulcer due to technical reasons (e.g. out-of-focus, motion-blurred or insufficient illumination); 2. Artifacts due to mucus, air bubbles, stool, or blood. 2)Obscured view due to poor bowel preparation; 3)Incomplete medical record; 4)Prior history of intestinal resection, fistula, or anastomosis.

Design outcomes

Primary

MeasureTime frameDescription
The diagnostic accuracyFrom 2023-07 to 2026-04The diagnostic accuracy (area under receiver operating characteristic curves, AUROC) of newly developed CADx system in prediction of final histopathology.

Secondary

MeasureTime frameDescription
SensitivityFrom 2023-07 to 2026-04The diagnostic sensitivity of newly developed CADx system in prediction of final histopathology.
SpecificityFrom 2023-07 to 2026-04The diagnostic specificity of newly developed CADx system in prediction of final histopathology.
Positive predictive valueFrom 2023-07 to 2026-04Positive predictive value of newly developed CADx system in prediction of final histopathology.
Negative predictive valueFrom 2023-07 to 2026-04Negative predictive value of newly developed CADx system in prediction of final histopathology.

Contacts

Primary ContactXiaobei Luo, PhD
luoxiaobei63@126.com17688881428

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026